Accelerating Ophthalmology Prior Authorization with Da Vinci PAS

The Specifics of Ophthalmology Prior Authorization Challenges

Ophthalmology prior authorization is uniquely complex, driven by chronic conditions requiring ongoing treatments such as anti-VEGF injections, and specialized procedures like premium IOL cataract surgery. These high-volume categories, alongside glaucoma and corneal procedures, demand precise documentation and often face scrutiny over medical necessity, leading to significant administrative overhead and potential delays in patient care. The AAO Preferred Practice Patterns serve as a critical framework, yet payer policies can introduce varied requirements.

Common Prior Authorization Triggers in Eye Care

• Anti-VEGF intravitreal injections: Aflibercept (Eylea, Eylea HD), ranibizumab (Lucentis), faricimab (Vabysmo), and biosimilars for wet AMD, DME, RVO.
• Cataract surgery with premium or specialty intraocular lenses (IOLs).
• Glaucoma surgical procedures, including micro-invasive glaucoma surgery (MIGS) and traditional interventions.
• Corneal procedures: DSAEK, DMEK, corneal cross-linking for keratoconus, and medically necessary refractive surgery.
• Oculoplastic procedures: Blepharoplasty for visual-field-affecting ptosis, ectropion/entropion repair, requiring medical necessity documentation.

Transforming Ophthalmology PA with Da Vinci PAS

The HL7 Da Vinci Prior Authorization Support (PAS) implementation guide standardizes the electronic exchange of prior authorization requests and responses using FHIR R4 resources. For ophthalmology, this means moving beyond fragmented payer portals and unstructured fax submissions towards a consistent, automated workflow. Klivira's Da Vinci PAS implementation facilitates structured data submission, enabling payers to process anti-VEGF re-authorizations and premium IOL requests with greater efficiency and transparency, aligning with the intent of CMS-0057-F.

Klivira's Da Vinci PAS Workflow for Ophthalmology

• **EMR-Integrated Coverage Discovery (Da Vinci CRD):** Initiates PA requirements at order entry for anti-VEGF or premium IOLs, surfacing payer-specific rules and documentation needs directly within your EMR.
• **Structured Documentation Assembly (Da Vinci DTR):** Populates payer-specific questionnaires from EMR FHIR data, ensuring all necessary clinical details—like OCT findings for anti-VEGF or visual field tests for ptosis repair—are captured and submitted as structured resources.
• **Standardized PAS Submission:** Bundles the `Claim` resource with structured clinical documentation for submission to payer PAS endpoints, replacing fragmented PDF attachments with actionable data.
• **Real-time Status Tracking & EMR Writeback:** Monitors decision status via `ClaimResponse` resources and writes authorization numbers and decision text directly back to the EMR, reducing manual follow-up.
• **Intelligent Payer Routing:** Automatically routes requests via Da Vinci PAS where available, falling back to X12 278 or payer portals for non-conformant payers, ensuring continuity.

Addressing Ophthalmology's Unique Workflow Constraints

Klivira's platform is designed to handle the specific operational realities of ophthalmology. For chronic anti-VEGF injection cycles, our system automates periodic re-authorization with response documentation, crucial for retina practices. We integrate logic for biosimilar substitution and cosmetic-vs-medical determinations for oculoplastics, leveraging structured data to mitigate common denial reasons like visual field documentation gaps or prior-treatment response gaps. This approach streamlines high-volume clinic-injection encounters and premium-lens patient counseling workflows.